1626 related articles for article (PubMed ID: 6428500)
1. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
2. Acetal phosphatidic acids: novel platelet aggregating agents.
Brammer JP; Maguire MH; Walaszek EJ; Wiley RA
Br J Pharmacol; 1983 May; 79(1):157-66. PubMed ID: 6871540
[TBL] [Abstract][Full Text] [Related]
3. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
Brammer JP; Kerecsen L; Maguire MH
Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
[TBL] [Abstract][Full Text] [Related]
4. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
5. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
6. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
Raz A
Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
9. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Packham MA; Livne AA; Ruben DH; Rand ML
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
[TBL] [Abstract][Full Text] [Related]
10. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
11. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
12. Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function.
Ouyang C; Huang TF
Toxicon; 1984; 22(5):705-18. PubMed ID: 6441310
[TBL] [Abstract][Full Text] [Related]
13. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
McCrea JM; Robinson P; Gerrard JM
Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
[TBL] [Abstract][Full Text] [Related]
15. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets.
Authi KS; Evenden BJ; Crawford N
Biochem J; 1986 Feb; 233(3):707-18. PubMed ID: 2939827
[TBL] [Abstract][Full Text] [Related]
17. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
18. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
Gross PL; Rand ML; Barrow DV; Packham MA
Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
[TBL] [Abstract][Full Text] [Related]
19. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity.
Barton PG
Biochim Biophys Acta; 1978 Feb; 539(1):98-113. PubMed ID: 623796
[TBL] [Abstract][Full Text] [Related]
20. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
Teng CM; Chen YH; Ouyang C
Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]